<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Avnet S</submitter><funding>Italian Association for Cancer Research</funding><pagination>5855</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8616358</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(22)</volume><pubmed_abstract>Osteosarcoma is the most frequent primary malignant bone tumour with an impressive tendency to metastasise. Highly proliferative tumour cells release a remarkable amount of protons into the extracellular space that activates the NF-kB inflammatory pathway in adjacent stromal cells. In this study, we further validated the correlation between tumour glycolysis/acidosis and its role in metastases. In patients, at diagnosis, we found high circulating levels of inflammatory mediators (IL6, IL8 and miR-136-5p-containing extracellular vesicles). IL6 serum levels significantly correlated with disease-free survival and &lt;sup>18&lt;/sup>F-FDG PET/CT uptake, an indirect measurement of tumour glycolysis and, hence, of acidosis. In vivo subcutaneous and orthotopic models, co-injected with mesenchymal strom</pubmed_abstract><journal>Cancers</journal><pubmed_title>The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma.</pubmed_title><pmcid>PMC8616358</pmcid><funding_grant_id>20153</funding_grant_id><funding_grant_id>21403</funding_grant_id><pubmed_authors>Longhi A</pubmed_authors><pubmed_authors>Roncuzzi L</pubmed_authors><pubmed_authors>Heymann D</pubmed_authors><pubmed_authors>Columbaro M</pubmed_authors><pubmed_authors>Perut F</pubmed_authors><pubmed_authors>Baldini N</pubmed_authors><pubmed_authors>Errani C</pubmed_authors><pubmed_authors>Dominici M</pubmed_authors><pubmed_authors>Di Pompo G</pubmed_authors><pubmed_authors>Consolino L</pubmed_authors><pubmed_authors>Nanni C</pubmed_authors><pubmed_authors>Avnet S</pubmed_authors><pubmed_authors>Lipreri MV</pubmed_authors><pubmed_authors>Longo DL</pubmed_authors><pubmed_authors>Zini N</pubmed_authors><pubmed_authors>Righi A</pubmed_authors><pubmed_authors>Cortini M</pubmed_authors><pubmed_authors>Grisendi G</pubmed_authors><pubmed_authors>Lemma S</pubmed_authors><pubmed_authors>Golinelli G</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma.</name><description>Osteosarcoma is the most frequent primary malignant bone tumour with an impressive tendency to metastasise. Highly proliferative tumour cells release a remarkable amount of protons into the extracellular space that activates the NF-kB inflammatory pathway in adjacent stromal cells. In this study, we further validated the correlation between tumour glycolysis/acidosis and its role in metastases. In patients, at diagnosis, we found high circulating levels of inflammatory mediators (IL6, IL8 and miR-136-5p-containing extracellular vesicles). IL6 serum levels significantly correlated with disease-free survival and &lt;sup>18&lt;/sup>F-FDG PET/CT uptake, an indirect measurement of tumour glycolysis and, hence, of acidosis. In vivo subcutaneous and orthotopic models, co-injected with mesenchymal strom</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2026-04-08T08:20:24.292Z</modification><creation>2025-05-29T19:23:31.383Z</creation></dates><accession>S-EPMC8616358</accession><cross_references><pubmed>34831016</pubmed><doi>10.3390/cancers13225855</doi></cross_references></HashMap>